Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on May 2, 2007
J Am Soc Nephrol 18: 1740-1753, 2007
© 2007 American Society of Nephrology
doi: 10.1681/ASN.2006010052

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
ASN.2006010052v1
18/6/1740    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahrabi, A. K.
Right arrow Articles by Devuyst, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahrabi, A. K.
Right arrow Articles by Devuyst, O.

Pathophysiology of Renal Disease and Progression

PKD1 Haploinsufficiency Causes a Syndrome of Inappropriate Antidiuresis in Mice

Ali K. Ahrabi*, Sara Terryn{dagger}, Giovanna Valenti{ddagger}, Nathalie Caron§, Claudine Serradeil-Le Gal||, Danielle Raufaste||, Soren Nielsen, Shigeo Horie**, Jean-Marc Verbavatz{dagger}{dagger} and Olivier Devuyst*

* Division of Nephrology, Université catholique de Louvain Medical School, Brussels, Belgium; {dagger} Laboratory of Cell Physiology, Center for Environmental Sciences, Hasselt University, Diepenbeek, Belgium; {ddagger} Department of Physiology, University of Bari, Bari, Italy; § Department of Physiology and Pharmacology, University of Mons-Hainaut, Mons, Belgium; || Sanofi-Aventis, Toulouse, France; The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark; ** Department of Urology, Teikyo University, Tokyo, Japan; and {dagger}{dagger} Cell and Molecular Imaging, CEA/Saclay, Gif-sur-Yvette, France

Address correspondence to: Dr. Olivier Devuyst, Division of Nephrology, UCL Medical School, 10 Avenue Hippocrate, B-1200 Brussels, Belgium. Phone: +32-2-764-5450; Fax: +32-2-764-5455; E-mail: devuyst{at}nefr.ucl.ac.be

Received for publication January 18, 2006. Accepted for publication March 9, 2007.

Mutations in PKD1 are associated with autosomal dominant polycystic kidney disease. Studies in mouse models suggest that the vasopressin (AVP) V2 receptor (V2R) pathway is involved in renal cyst progression, but potential changes before cystogenesis are unknown. This study used a noncystic mouse model to investigate the effect of Pkd1 haploinsufficiency on water handling and AVP signaling in the collecting duct (CD). In comparison with wild-type littermates, Pkd1+/– mice showed inappropriate antidiuresis with higher urine osmolality and lower plasma osmolality at baseline, despite similar renal function and water intake. The Pkd1+/– mice had a decreased aquaretic response to both a water load and a selective V2R antagonist, despite similar V2R distribution and affinity. They showed an inappropriate expression of AVP in brain, irrespective of the hypo-osmolality. The cAMP levels in kidney and urine were unchanged, as were the mRNA levels of aquaporin-2 (AQP2), V2R, and cAMP-dependent mediators in kidney. However, the (Ser256) phosphorylated AQP2 was upregulated in Pkd1+/– kidneys, with AQP2 recruitment to the apical plasma membrane of CD principal cells. The basal intracellular Ca2+ concentration was significantly lower in isolated Pkd1+/– CD, with downregulated phosphorylated extracellular signal–regulated kinase 1/2 and decreased RhoA activity. Thus, in absence of cystic changes, reduced Pkd1 gene dosage is associated with a syndrome of inappropriate antidiuresis (positive water balance) reflecting decreased intracellular Ca2+ concentration, decreased activity of RhoA, recruitment of AQP2 in the CD, and inappropriate expression of AVP in the brain. These data give new insights in the potential roles of polycystin-1 in the AVP and Ca2+ signaling and the trafficking of AQP2 in the CD.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
Y. Pirson
Does TNF-{alpha} enhance cystogenesis in ADPKD?
Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3773 - 3775.
[Full Text] [PDF]


Home page
CJASNHome page
V. E. Torres
Role of Vasopressin Antagonists
Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1212 - 1218.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP